Michael Scolaro

Michael Scolaro

Sep 19, 2017

Group 6 Copy 156
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can plant-based antimicrobials act as an alternative to therapeutic antibiotics?

    Antibiotic overuse has led to antimicrobial resistance (AMR). The World Health Organisation (WHO) ranks...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Searching for Genetic Clues in Autism with Family Trio Sequencing

    Autism is a complex condition, but recent research shows that genetics may play a larger role than previously...

    Backer Badge Funded